STACI FIOCK: Open Payments
NPI 1669213104 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 129 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,311 · 2025 $2,381
Food & beverage: $2,381
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 27 | $500 |
| ABBVIE INC. | 31 | $492 |
| UCB, Inc. | 12 | $286 |
| GlaxoSmithKline, LLC. | 12 | $199 |
| ANI Pharmaceuticals, Inc. | 12 | $144 |
| GENZYME CORPORATION | 5 | $137 |
| Invivyd Inc | 3 | $76 |
| Mallinckrodt Hospital Products Inc. | 2 | $68 |
| PFIZER INC. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
Products named: RINVOQ, Bimzelx, KRYSTEXXA, BENLYSTA, KEVZARA, PURIFIED CORTROPHIN GEL, SKYRIZI, OTEZLA.
Industry payments across TX — which companies pay providers there.
